
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is well positioned to benefit from sustained share gains, with total HSA members up 8% year over year, custodial assets up 14%, and renewals tracking well above 90%, while rising deductibles and broader HSA eligibility continue to expand its addressable market. Its digital platform strengthens the moat: the app surpassed 1.4 million monthly active users in July, marketplace traffic hit a record 500,000 unique visitors in a week, and only about 9% of HSA members invest today, leaving meaningful monetization upside through products like SimplyInvest and Enhanced Rates. Management’s emphasis on AI, automation, and a larger enterprise pipeline supports margin expansion and lower servicing costs, reinforcing the view that HealthEquity can outgrow the market while improving profitability.
Bears say
HealthEquity is vulnerable to a softer labor market, because lower employment and weaker high-income job growth can slow HSA contributions, new account growth, and average balance expansion, pressuring a business that depends on consumer savings accumulation. Its earnings mix is also sensitive to falling interest rates and investment returns, and the cited downside case assumes a recession-like environment with only 5% topline growth and 200 bps of margin contraction in 2027. In addition, competition, regulatory risk around tax-advantaged benefits, cybersecurity threats, and possible shifts toward alternative payment methods could all limit valuation support despite solid operational execution.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares